I have been following this stock for a few years. Most regular Dr.s never heard of it, unless you are a sharp urologist (most are not). The drug deserves to be approved as most treatments are very limited for aggressive Pca. Besides the technology may be applicable to other cancers.
Jokes aside ones medical doctor is not in general a good source of information about cutting edge medical technologies. Most are trained in established applied sciences which are currentley being used. Even research scientists are usually limited to their area of expertise. If one wants to be informed start with a companies web site and then expand to medical journals pertaining to it's technologies. However, most will find comprehension difficult unless they have some bioscience background.